Virginia Commonwealth University: Heart Failure trials
The registry lists 20 Heart Failure studies with Virginia Commonwealth University as lead sponsor. 1 are open to participants now and 10 have results posted.
Phase 1 3Phase 2 10Phase 3 2Phase 4 2No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/ValsartanRecruitingNCT05194111Phase 1/2
- Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2CompletedNCT03797001Phase 2Results posted
- Treatment of Diabetes in Patients With Systolic Heart FailureCompletedNCT02920918Phase 4Results posted
- Interleukin-1 Blockade in HF With Preserved EFCompletedNCT02173548Phase 2Results posted
- Interleukin-1 Blockade in Recently Decompensated Heart FailureCompletedNCT01936909Phase 2/3Results posted
- Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)CompletedNCT01936844Phase 2/3Results posted
- Safety and Efficacy of Doxycycline in Patients With Non-Ischemic CardiomyopathyTerminatedNCT01935622Phase 2Results posted
- Nesiritide and Renal Function After the Total Artificial HeartTerminatedNCT01836809Phase 4Results posted
- Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection FractionCompletedNCT01542502Not applicableResults posted
- Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart FailureCompletedNCT01300650Phase 1/2Results posted
- Anakinra to Prevent Adverse Post-infarction Remodeling (2)CompletedNCT01175018Phase 2Results posted
- The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)CompletedNCT06062966Phase 1
- Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart FailureActive, not recruitingNCT05177822Phase 2
- Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Obesity and HFpEFCompletedNCT03966755Not applicable
- Chronic Kidney Disease and Heart Failure With Preserved Ejection Fraction: The Role of Mitochondrial DysfunctionCompletedNCT03960073Not applicable
- Unsaturated Fatty Acids Enriched-diet to Improve Cardiorespiratory Fitness, Metabolic Flexibility and Glucose Tolerance in Obese PatientsCompletedNCT03310099Not applicable
- Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney DiseaseWithdrawnNCT03062176Phase 2
- SGLT2 Inhibition in Diabetes and Heart FailureCompletedNCT02862067
- Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated High Sensitivity C-reactive Protein (Hs-CRP)CompletedNCT01900600Not applicable
- Implantable Cardioverter Defibrillator (ICD) Function During Ventricular Assist Device (VAD) ImplantationCompletedNCT01576562